COCP News and Press, Cocrystal Pharma Inc. From 07/29/21

BOTHELL, Wash., July 29, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that its SARS-CoV-2 3CL protease lead CDI-45205 and several analogs showed potent in vitro activity against the SARS-CoV-2...

Drug-resistant superbugs have threatened human health for decades. The situation is getting worse because of the shortage of new antibiotics. But what if we changed the way we aim to treat them, and trained our cells to kill these invaders instead of relying on antibiotics to do the dirty work...

US biotechnology company Cocrystal Pharma (COCP) has been selected to join the Russell Microcap Index.The move is effective June 28, 2021, after the U.S. market opens.James Martin, Cocrystal's interim co-Chief Executive Officer and Chief Financial Officer, said, "This is a notable milestone f...

BOTHELL, Wash., June 28, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machiner...

The Product Pipeline Advances Cocrystal announced that it has completed studies to file an IND for CC-42344, its PB2 inhibitor for the treatment of seasonal and pandemic influenza A. The first Phase 1 study is planned for 3Q21. CC-42334 Has A Unique Mechanism Of Action CC-42334 was developed u...

Cocrystal Pharma (COCP) announces the completion of IND-enabling studies with its potent, broad-spectrum PB2 inhibitor CC-42344 for the treatment of seasonal and pandemic influenza A and plans to initiate Phase 1 clinical development of CC-42344 in Q3 2021. “The planned Phase 1 study w...

BOTHELL, Wash., June 23, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machiner...

Will These Penny Stocks Continue to Show Momentum? Penny stocks are heating up. This is characterized by large intraday movements, and investors showing heightened bullish interest. While not all penny stocks are winners, it can be easy to find the best penny stocks to buy by fo...

Cocrystal Pharma (COCP) jumps 11.2% premarket after announcing that its protease inhibitor CDI-45205 is active against SARS-CoV-2 and two variants.Two reference inhibitors including remdesivir and PF-00835231 were included in the study as comparators.Results showed CD...

BOTHELL, Wash., June 14, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication mach...